Back to search

Article

EZH2 Inhibition Reshapes 3D Chromatin Architecture to Induce Immunogenic Phenotype in Small Cell Lung Cancer

2026-01-28

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The histone methyltransferase EZH2, enzymatic core of the trimeric polycomb repressive complex 2 (PRC2), has been shown to promote small cell lung cancer (SCLC) survival through epigenetic silencing of multiple targets including Class I MHC molecules ( HLA-A/B ) and DNA repair factors ( SLFN11 ). Treatment of SCLC cells with EZH2 inhibitors in vitro can reactivate express...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
33a6e207-853b-5a7c-baeb-576be95f4d1e
DOI
10.64898/2026.01.26.701784
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EZH2 Inhibition Reshapes 3D Chromatin Architecture to Induce Immunogenic Phenotype in Small Cell Lung CancerDOI 10.64898/2026.01.26.701784
Select a neighboring publication to make it the new centre.